Bisphosphonates in osteoporosis?
- 1 January 1993
- journal article
- review article
- Published by Springer Nature in Osteoporosis International
- Vol. 3 (S1) , 230-236
- https://doi.org/10.1007/bf01621915
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Prevention of glucocorticoid-induced osteoporosisJournal of Bone and Mineral Research, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Zinc excretion in osteoporotic womenJournal of Bone and Mineral Research, 1990
- Effects of a bisphosphonate (1-hydroxy ethylidene-1,1 bisphosphonic acid) on osteoclast number during prolonged bed rest in healthy humansMetabolism, 1989
- Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateJournal of Bone and Mineral Research, 1989
- PREVENTION OF STEROID-INDUCED OSTEOPOROSIS WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (APD)The Lancet, 1988
- The long-term skeletal effects of EHDP in dogsMetabolic Bone Disease and Related Research, 1981
- Apd in paget's disease of bone role of the mononuclear phagocyte system?Arthritis & Rheumatism, 1980
- TREATMENT OF PAGET'S DISEASE WITH (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979